FDA Approves Advanced Therapy Designation for AskBio’s Parkinson’s Disease Gene Therapy: A Regenerative Medicine Milestone
FDA Grants RMAT Designation to AskBio’s Parkinson’s Gene Therapy FDA Grants RMAT Designation to AskBio’s Parkinson’s Gene therapy Berlin, Germany, and Research Triangle Park, N.C.,February 19,2025 – AskBio Inc.,a Bayer AG subsidiary,announced its investigational gene therapy,AB-1005,for parkinson’s disease (PD) received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S.Food and Drug Management (FDA). This designation … Read more